Obesity, particularly visceral obesity, plays a role in the development of metabolic alterations through mechanisms such as insulin resistance, low-grade chronic inflammation, and endocrine dysfunction of adipose tissue, promoting the onset of dyslipidemia, such as increased cholesterol and triglyceride levels. Here, INS is linked to metabolic syndrome.